Skip to main content
Sunshine Biopharma, Inc. (SBFM)
NASDAQ: SBFM · Real-Time Price · USD
1.103
-0.007 (-0.67%)
Mar 9, 2026, 1:21 PM EDT - Market open

Sunshine Biopharma Revenue

Sunshine Biopharma had revenue of $9.42M in the quarter ending September 30, 2025, with 11.64% growth. This brings the company's revenue in the last twelve months to $37.32M, up 13.24% year-over-year. In the year 2024, Sunshine Biopharma had annual revenue of $34.87M with 44.75% growth.

Revenue (ttm)
$37.32M
Revenue Growth
+13.24%
P/S Ratio
0.15
Revenue / Employee
$717,764
Employees
52
Market Cap
5.41M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202434.87M10.78M44.75%
Dec 31, 202324.09M19.75M454.42%
Dec 31, 20224.35M4.12M1,802.41%
Dec 31, 2021228.43K157.02K219.88%
Dec 31, 202071.41K50.29K238.10%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
IM Cannabis 37.61M
Biofrontera 37.16M
cbdMD 19.09M
Sonoma Pharmaceuticals 17.72M
RedHill Biopharma 9.55M
InMed Pharmaceuticals 4.51M
China Pharma Holdings 4.05M
Akanda 836.66K
Revenue Rankings

SBFM News

More News